International Pancreatic Surgery Outcomes Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-30

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

"Snapshot" study worldwide over 3 months in 2021. Provide a verified record of true morbidity and mortality. Identify modifiable predicting factors of outcome. Obtain PubMed citable co-authorship,

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnostic Prediction of Pancreatic Masses

NCT06724055

Pancreatic Masses

COMPLETED

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

NCT07182136

Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy

COMPLETED

Observational Study of Biomarker During Liver Surgery

NCT02102971

Liver Cancer Hepatobiliary Tract Adenomas and Carcinomas

TERMINATED

PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery

NCT07248527

Pancreatectomy Pancreatic Surgery Intensive Care (ICU) +5 more

ACTIVE_NOT_RECRUITING

Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy

NCT05616403

Pancreatic Neoplasms

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The PancreasGroup.org team is conducting a "snapshot" clinical study investigating the outcomes of pancreatic surgery worldwide. This "collaborative" model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time.

There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery.

The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Neoplasms Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing pancreatic surgery

Patients undergoing any type of pancreatic surgery.

Pancreatic surgery

Intervention Type PROCEDURE

Open, laparoscopic or robotic surgery of the pancreas

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pancreatic surgery

Open, laparoscopic or robotic surgery of the pancreas

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All indications (including benign and malignant)
* Open, laparoscopic or robotic.
* Elective or emergency.
* Partial or total pancreatectomies.
* Pancreatic tumour enucleations.
* Procedures with concomitant vascular or other organ resections.
* Pancreatic duct drainage procedures (e.g. Frey, Puestow, or Beger)
* Adults 18 years of age or older.

Exclusion Criteria

* Pancreas or islet cell transplantation.
* Transcutaneous or transgastric imaging-guided ablation (e.g. RFA) or electroporation (e.g. NanoKnife).
* Endoscopic (e.g. endoscopic retrograde cholangiopancreatography, stent or lithotripsy) procedures.
* Endoscopic transgastric and surgical necrosectomies excluded.
* Patients less than 18 years of age excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No